Well-controlled MG Linked to Better COVID-19 Outcomes in Small Study
Patients with well-controlled myasthenia gravis (MG) and no co-existing conditions, or comorbidities, are more likely to have milder COVID-19…
Articles by Yedida Y Bogachkov PhD
Lack of Symptom Fluctuations in Patients Linked to Delayed Diagnosis
People with myasthenia gravis (MG) who lack or have subtle symptom fluctuations may face a delayed diagnosis of…
Soleo Health Selected as US Distributor for Vyvgart for gMG
Soleo Health, a pharmacy specializing in infusion therapies, will serve as the U.S. distributor that will administer Vyvgart (efgartigimod),…
Tacrolimus Safe and Effective as Own Immunotherapy for MG, Study Finds
Tacrolimus is effective and safe as a single-agent immunotherapy for people with myasthenia gravis (MG), and its use led…
Merck Acquiring Cladribine as Potential Generalized MG Treatment
Merck KGaA has acquired Chord Therapeutics and the rights to continue developing CRD1 (cladribine), Chord’s lead candidate for treatment…
Comorbidities, Common in MG, Appear to Rise as Patients Age
Comorbidities — co-existing illnesses like hypertension — tend to be more common in older patients with myasthenia gravis (MG) and to…
Study Examines Risks of Prolonged Ventilation After Thymus Surgery
In patients with myasthenia gravis (MG) with an associated thymus tumor, being male, having poorer lung function, more severe…